You need to enable JavaScript to run this app.
Recon: Takeda CEO Weber to step down; Merck halts PAH drug trial early on strong efficacy data
Recon
Jason Scott
Biologics/ biosimilars/ vaccines
Europe
Global
Medical Devices
North America
Pharmaceuticals
Regulatory Intelligence/Policy
United States